Effects of alterations in cannabinoid signaling, alone and in combination with morphine, on pain-elicited and pain-suppressed behavior in mice

Journal of Pharmacology and Experimental Therapeutics

Volumn 342, Issue 1, 2012, Pages 177-187

  Miller, Laurence L ^a   Picker, Mitchell J ^a   Umberger, Michael D ^a   Schmidt, Karl T ^a   Dykstra, Linda A ^a  

^a The University of North Carolina at Chapel Hill   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; ACETIC ACID; CANNABINOID; CYCLOHEXYLCARBAMIC ACID 3' CARBAMOYLBIPHENYL 3 YL ESTER; MORPHINE SULFATE; N (4 HYDROXYPHENYL)ARACHIDONAMIDE; RIMONABANT;

ANALGESIC ACTIVITY; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CATALEPSY; CONTROLLED STUDY; DIET RESTRICTION; DOSE RESPONSE; DRUG EFFICACY; DRUG POTENCY; DRUG POTENTIATION; HOT PLATE TEST; MALE; MOUSE; NOCICEPTION; NOCICEPTIVE STIMULATION; NONHUMAN; PAIN; PRIORITY JOURNAL; RUNNING; SIGNAL TRANSDUCTION; STIMULUS RESPONSE; WRITHING TEST;

AMIDOHYDROLASES; ANALGESICS; ANIMALS; ARACHIDONIC ACIDS; BENZAMIDES; CANNABINOID RECEPTOR MODULATORS; CARBAMATES; CYCLOHEXANOLS; ENDOCANNABINOIDS; MALE; MICE; MICE, INBRED C57BL; MORPHINE; NOCICEPTION; PAIN; POLYUNSATURATED ALKAMIDES; RECEPTOR, CANNABINOID, CB1;

EID: 84862495714     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.112.191478     Document Type: Article

References (49)

1. Adermark L and Lovinger DM (2009) Frequency-dependent inversion of net striatal output by endocannabinoid-dependent plasticity at different synaptic inputs. J Neurosci 29:1375-1380.
2. Agarwal N, Pacher P, Tegeder I, Amaya F, Constantin CE, Brenner GJ, Rubino T, Michalski CW, Marsicano G, Monory K, et al. (2007) Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors. Nat Neurosci 10:870-879. (Pubitemid 47013432)
3. Booker L, Kinsey SG, Abdullah RA, Blankman JL, Long JZ, Ezzili C, Boger DL, Cravatt BF, and Lichtman AH (2012) The fatty acid amide hydrolase (FAAH) inhibitor PF-3845 acts in the nervous system to reverse LPS-induced tactile allodynia in mice. Br J Pharmacol 165:2485-2496.
4. Cichewicz DL and McCarthy EA (2003) Antinociceptive synergy between Δ9-tetrahydrocannabinol and opioids after oral administration. J Pharmacol Exp Ther 304:1010-1015. (Pubitemid 36254412)
5. Clapper JR, Moreno-Sanz G, Russo R, Guijarro A, Vacondio F, Duranti A, Tontini A, Sanchini S, Sciolino NR, Spradley JM, et al. (2010) Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism. Nat Neurosci 13:1265-1270.
6. Clement AB, Hawkins EG, Lichtman AH, and Cravatt BF (2003) Increased seizure susceptibility and proconvulsant activity of anandamide in mice lacking fatty acid amide hydrolase. J Neurosci 23:3916-3923. (Pubitemid 36958497)
7. Costa B, Bettoni I, Petrosino S, Comelli F, Giagnoni G, and Di Marzo V (2010) The dual fatty acid amide hydrolase/TRPV1 blocker, N-arachidonoyl- serotonin, relieves carrageenan-induced inflammation and hyperalgesia in mice. Pharmacol Res 61:537-546.
8. Costa B, Siniscalco D, Trovato AE, Comelli F, Sotgiu ML, Colleoni M, Maione S, Rossi F, and Giagnoni G (2006) AM404, an inhibitor of anandamide uptake, prevents pain behaviour and modulates cytokine and apoptotic pathways in a rat model of neuropathic pain. Br J Pharmacol 148:1022-1032. (Pubitemid 44543620)
9. Cox ML, Haller VL, and Welch SP (2007) Synergy between Δ9-tetrahydrocannabinol and morphine in the arthritic rat. Eur J Pharmacol 567:125-130. (Pubitemid 46782831)
10. Cravatt BF, Demarest K, Patricelli MP, Bracey MH, Giang DK, Martin BR, and Lichtman AH (2001) Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase. Proc Natl Acad Sci U S A 98:9371-9376. (Pubitemid 32743923)
11. da Fonseca Pacheco D, Klein A, de Castro Perez A, da Fonseca Pacheco CM, de Francischi JN, and Duarte ID (2008) The μ-opioid receptor agonist morphine, but not agonists at δ- or κ-opioid receptors, induces peripheral antinociception mediated by cannabinoid receptors. Br J Pharmacol 154:1143-1149. (Pubitemid 351923053)
12. Diaz S, Farhang B, Hoien J, Stahlman M, Adatia N, Cox JM, and Wagner EJ (2009) Sex differences in the cannabinoid modulation of appetite, body temperature and neurotransmission at POMC synapses. Neuroendocrinology 89:424-440.
13. Fegley D, Gaetani S, Duranti A, Tontini A, Mor M, Tarzia G, and Piomelli D (2005) Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3′-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation. J Pharmacol Exp Ther 313:352-358. (Pubitemid 40411361)
14. Fegley D, Kathuria S, Mercier R, Li C, Goutopoulos A, Makriyannis A, and Piomelli D (2004) Anandamide transport is independent of fatty-acid amide hydrolase activity and is blocked by the hydrolysis-resistant inhibitor AM1172. Proc Natl Acad Sci U S A 101:8756-8761. (Pubitemid 38745844)
15. Finn DP, Beckett SR, Roe CH, Madjd A, Fone KC, Kendall DA, Marsden CA, and Chapman V (2004) Effects of coadministration of cannabinoids and morphine on nociceptive behaviour, brain monoamines and HPA axis activity in a rat model of persistent pain. Eur J Neurosci 19:678-686. (Pubitemid 38241307)
16. Haller VL, Stevens DL, and Welch SP (2008) Modulation of opioids via protection of anandamide degradation by fatty acid amide hydrolase. Eur J Pharmacol 600:50-58.
17. Howlett AC, Barth F, Bonner TI, Cabral G, Casellas P, Devane WA, Felder CC, Herkenham M, Mackie K, Martin BR, Mechoulam R, and Pertwee RG (2002) International union of pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev 54:161-202. (Pubitemid 34575709)
18. Institute of Laboratory Animal Resources (2011) Guide for the Care and Use of Laboratory Animals, Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council, Washington, DC.
19. Järbe TU and DiPatrizio NV (2005) Δ9-THC induced hyperphagia and tolerance assessment: interactions between the CB1 receptor agonist Δ9-THC and the CB1 receptor antagonist SR-141716 (rimonabant) in rats. Behav Pharmacol 16:373-380. (Pubitemid 41404808)
20. Jayamanne A, Greenwood R, Mitchell VA, Aslan S, Piomelli D, and Vaughan CW (2006) Actions of the FAAH inhibitor URB597 in neuropathic and inflammatory chronic pain models. Br J Pharmacol 147:281-288. (Pubitemid 43214685)
21. Justinova Z, Munzar P, Panlilio LV, Yasar S, Redhi GH, Tanda G, and Goldberg SR (2008) Blockade of THC-seeking behavior and relapse in monkeys by the cannabinoid CB1-receptor antagonist rimonabant. Neuropsychopharmacology 33:2870-2877.
22. Kathuria S, Gaetani S, Fegley D, Valiño F, Duranti A, Tontini A, Mor M, Tarzia G, La Rana G, Calignano A, et al. (2003) Modulation of anxiety through blockade of anandamide hydrolysis. Nat Med 9:76-81. (Pubitemid 36098263)
23. Kinsey SG, Long JZ, O'Neal ST, Abdullah RA, Poklis JL, Boger DL, Cravatt BF, and Lichtman AH (2009) Blockade of endocannabinoid-degrading enzymes attenuates neuropathic pain. J Pharmacol Exp Ther 330:902-910.
24. Li D, Olszewski PK, Shi Q, Grace MK, Billington CJ, Kotz CM, and Levine AS (2006) Effect of opioid receptor ligands injected into the rostral lateral hypothalamus on c-fos and feeding behavior. Brain Res 1096:120-124. (Pubitemid 43928920)
25. Lichtman AH, Leung D, Shelton CC, Saghatelian A, Hardouin C, Boger DL, and Cravatt BF (2004a) Reversible inhibitors of fatty acid amide hydrolase that promote analgesia: evidence for an unprecedented combination of potency and selectivity. J Pharmacol Exp Ther 311:441-448. (Pubitemid 39391527)
26. Lichtman AH, Shelton CC, Advani T, and Cravatt BF (2004b) Mice lacking fatty acid amide hydrolase exhibit a cannabinoid receptor-mediated phenotypic hypoalgesia. Pain 109:319-327. (Pubitemid 38638709)
27. Manzanedo C, Aguilar MA, Rodríguez-Arias M, Navarro M, and Miñarro J (2004) Cannabinoid agonist-induced sensitization to morphine place preference in mice. Neuroreport 15:1373-1377. (Pubitemid 38757284)
28. Massi P, Vaccani A, Romorini S, and Parolaro D (2001) Comparative characterization in the rat of the interaction between cannabinoids and opiates for their immunosuppressive and analgesic effects. J Neuroimmunol 117:116-124. (Pubitemid 32595499)
29. Miller LL, Picker MJ, Schmidt KT, and Dykstra LA (2011) Effects of morphine on pain-elicited and pain-suppressed behavior in CB1 knockout and wildtype mice. Psychopharmacology 215:455-465.
30. Mitrirattanakul S, Ramakul N, Guerrero AV, Matsuka Y, Ono T, Iwase H, Mackie K, Faull KF, and Spigelman I (2006) Site-specific increases in peripheral cannabinoid receptors and their endogenous ligands in a model of neuropathic pain. Pain 126:102-114. (Pubitemid 44781351)
31. Moore SA, Nomikos GG, Dickason-Chesterfield AK, Schober DA, Schaus JM, Ying BP, Xu YC, Phebus L, Simmons RM, Li D, et al. (2005) Identification of a high-affinity binding site involved in the transport of endocannabinoids. Proc Natl Acad Sci USA 102:17852-17857. (Pubitemid 41803586)
32. Negus SS and Rice KC (2009) Mechanisms of withdrawal-associated increases in heroin self-administration: pharmacologic modulation of heroin vs food choice in heroin-dependent rhesus monkeys. Neuropsychopharmacology 34:899-911.
33. Negus SS, Vanderah TW, Brandt MR, Bilsky EJ, Becerra L, and Borsook D. S. (2006) Preclinical assessment of candidate analgesic drugs: recent advances and future challenges. J Pharmacol Exp Ther 319:507-514.
34. Norwood CS, Cornish JL, Mallet PE, and McGregor IS (2003) Pre-exposure to the cannabinoid receptor agonist CP 55940 enhances morphine behavioral sensitization and alters morphine self-administration in Lewis rats. Eur J Pharmacol 465:105-114. (Pubitemid 36332282)
35. 1 receptor. Br J Pharmacol 158:225-231.
36. Pascual D, Goicoechea C, Suardíaz M, and Martín MI (2005) A cannabinoid agonist, WIN 55,212-2, reduces neuropathic nociception induced by paclitaxel in rats. Pain 118:23-34. (Pubitemid 41566582)
37. Pereira Do Carmo G, Stevenson GW, Carlezon WA, and Negus SS (2009) Effects of pain- and analgesia-related manipulations on intracranial self-stimulation in rats: further studies on pain-depressed behavior. Pain 144:170-177.
38. Pertwee RG, Howlett AC, Abood ME, Alexander SP, Di Marzo V, Elphick MR, Greasley PJ, Hansen HS, Kunos G, Mackie K, et al. (2010) International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB1 and CB2. Pharmacol Rev 62:588-631.
39. Russo R, Loverme J, La Rana G, Compton TR, Parrott J, Duranti A, Tontini A, Mor M, Tarzia G, Calignano A, et al. (2007) The fatty acid amide hydrolase inhibitor URB597 (cyclohexylcarbamic acid 3′-carbamoylbiphenyl-3-yl ester) reduces neuropathic pain after oral administration in mice. J Pharmacol Exp Ther 322:236-242. (Pubitemid 46956375)
40. Smith MA, Greene-Naples JL, Lyle MA, Iordanou JC, and Felder JN (2009) The effects of repeated opioid administration on locomotor activity: I. Opposing actions of μ and κ receptors. J Pharmacol Exp Ther 330:468-475.
41. Smith PB and Martin BR (1992) Spinal mechanisms of Δ9- tetrahydrocannabinol-induced analgesia. Brain Res 578:8-12.
42. Smith PB, Welch SP, and Martin BR (1994) Interactions between Δ9-tetrahydrocannabinol and κ opioids in mice. J Pharmacol Exp Ther 268:1381-1387.
43. Solinas M, Panlilio LV, Tanda G, Makriyannis A, Matthews SA, and Goldberg SR (2005) Cannabinoid agonists but not inhibitors of endogenous cannabinoid transport or metabolism enhance the reinforcing efficacy of heroin in rats. Neuropsychopharmacology 30:2046-2057. (Pubitemid 43093504)
44. Stevenson GW, Bilsky EJ, and Negus SS (2006) Targeting pain-suppressed behaviors in preclinical assays of pain and analgesia: effects of morphine on acetic acid-suppressed feeding in C57BL/6J mice. J Pain 7:408-416. (Pubitemid 43794888)
45. Stevenson GW, Cormier J, Mercer H, Adams C, Dunbar C, Negus SS, and Bilsky EJ (2009) Targeting pain-depressed behaviors in preclinical assays of pain and analgesia: drug effects on acetic acid-depressed locomotor activity in ICR mice. Life Sci 85:309-315.
46. Wang YQ, Guo J, Wang SB, Fang Q, He F, and Wang R (2008) Neuropeptide FF receptors antagonist, RF9, attenuates opioid-evoked hypothermia in mice. Peptides 29:1183-1190.
47. Welch SP (2009) Interaction of the cannabinoid and opioid systems in the modulation of nociception. Int Rev Psychiatry 21:143-151.
48. Welch SP and Stevens DL (1992) Antinociceptive activity of intrathecally administered cannabinoids alone, and in combination with morphine, in mice. J Pharmacol Exp Ther 262:10-18.
49. Welch SP, Thomas C, and Patrick GS (1995) Modulation of cannabinoid-induced antinociception after intracerebroventricular versus intrathecal administration to mice: possible mechanisms for interaction with morphine. J Pharmacol Exp Ther 272:310-321.